Sun Pharma eyes to divest manufacturing plant in Ireland: Report

10 Sep 2015 Evaluate

In a bid to control costs that have spiralled since it bought Ranbaxy Laboratories, Sun Pharmaceutical Industries is reportedly looking to divest a manufacturing plant in Ireland.

The world’s fifth largest generic drugmaker has been working on resolving issues at Ranbaxy's India-based drug manufacturing sites, all of which have been banned from exporting to its largest market, the United States, over quality control issues.

Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business, economies of scale and an extremely skilled team enable the company to deliver quality products in a timely manner at affordable prices.

Sun Pharma Inds. Share Price

1722.00 1.60 (0.09%)
02-Jan-2026 14:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.00
Dr. Reddys Lab 1252.10
Cipla 1508.10
Zydus Lifesciences 914.60
Lupin 2103.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×